HomeINNPF • OTCMKTS
add
Innocan Pharma Corp
Previous close
$0.091
Year range
$0.17 - $0.30
Market cap
68.22M CAD
Avg Volume
913.00
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 8.64M | 176.96% |
Operating expense | 7.47M | 141.46% |
Net income | 337.00K | 164.81% |
Net profit margin | 3.90 | 123.41% |
Earnings per share | — | — |
EBITDA | 542.00K | 226.93% |
Effective tax rate | 33.33% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.19M | 53.84% |
Total assets | 8.72M | 47.68% |
Total liabilities | 2.68M | 197.55% |
Total equity | 6.04M | — |
Shares outstanding | 280.66M | — |
Price to book | 4.54 | — |
Return on assets | 14.98% | — |
Return on capital | 24.72% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 337.00K | 164.81% |
Cash from operations | 675.00K | 194.67% |
Cash from investing | -3.00K | 66.67% |
Cash from financing | -5.00K | 16.67% |
Net change in cash | 594.00K | 182.96% |
Free cash flow | 18.50K | 103.12% |
About
Founded
2018
Website
Employees
8
